Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas

American Journal of Gastroenterology

Volumn 95, Issue 1, 2000, Pages 255-263

  Tashima, Satoshi ^a   Shimada, Shinya ^a   Yamaguchi, Kenji ^a   Tsuruta, Junji ^a   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN PHOSPHORYLASE; PROTEIN P53;

ARTICLE; BRAIN; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; DISEASE MARKER; ENZYME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADENOMA; CARCINOMA; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; ISOENZYMES; PHOSPHORYLASES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033986404     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00751-0     Document Type: Article

References (47)

1. Morson B.C. The polyp-cancer sequence in the large bowel. Proc R Soc Med. 67:1974;451-457.
2. Fearon E.R., Jones P.A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 6:1992;2783-2790.
3. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Eng J Med. 319:1988;525-532.
4. Shimoda T., Ikegami M., Fujisaki J., et al. Early colorectal carcinoma with special reference to its development de novo. Cancer. 64:1989;1138-1146.
5. Minamoto T., Sawaguchi K., Mai M., et al. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res. 54:1994;2841-2844.
6. Yamagata S., Muto T., Uchida Y., et al. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Jpn J Cancer Res. 85:1994;147-151.
7. Mueller J., Mueller E., Hoepner I., et al. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma A comparative immunohistochemical study . J Pathol. 180:1996;259-265.
8. Cori C.F., Cori G.T. Mechanism and formation of hexosemonophosphate in muscle and isolation of a new phosphate ester. Proc Soc Exp Biol Med. 34:1936;702-712.
9. Davis C.H., Schliselfeld L.H., Wolf D.P., et al. Interrelationships among glycogen phosphorylase isozymes. J Biol Chem. 242:1967;4824-4833.
10. Newgard C.B., Hwang P.K., Fletterick R.J. The family of glycogen phosphorylase Structure and function . Crit Rev Biochem Mol Biol. 24:1989;69-99.
11. Shimada S., Maeno M., Akagi M., et al. Immunohistochemical detection of glycogen phosphorylase isoenzymes in rat and human tissues. Histochem J. 18:1986;334-338.
12. Nakano K., Hwang P., Fletterick R.J. Complete cDNA sequence for rabbit muscle glycogen phosphorylase. FEBS Lett. 204:1986;283-287.
13. Newgard C.B., Littman D.R., Genderen C.V., et al. Human brain glycogen phosphorylase. J Biol Chem. 263:1988;3850-3857.
14. Sato K., Morris H.P., Weinhouse S. Phosphorylase A new isozyme in rat hepatic tumors and fetal liver . Science. 178:1972;879-881.
15. Shimada S., Maeno M., Misumi A., et al. Antigen reversion of glycogen phosphorylase isoenzyme in carcinoma and proliferative zone of intestinal metaplasia of the human stomach. Gastroenterology. 93:1987;35-40.
16. Gelinas R.P., Froman B.E., McElroy F., et al. Human brain glycogen phosphorylase Characterization of fetal cDNA and genomic sequence . Mol Brain Res. 6:1989;177-185.
17. Takashi M., Koshikawa T., Kurobe N., et al. Elevated concentrations of brain type glycogen phosphorylase in renal cell carcinoma. Jpn J Cancer Res. 80:1989;975-980.
18. Hashimoto K., Tamura K., Otani H., et al. Histochemical and immunohistochemical studies related to the role of glycogen in human developing digestive organs. Anat Embryol. 192:1995;497-505.
19. Shimada S., Maeno M., Misumi A., et al. Histochemical study of phosphorylase in proliferating cells of intestinal metaplasia and carcinoma of the human stomach. Scand J Gastroenterol. 19:1984;965-970.
20. Shimada S., Honmyo U., Yagi Y., et al. Expression of glycogen phosphorylase activity in minute gastric carcinoma. Am J Gastroenterol. 87:1992;1230-1231.
21. Matsuzaki H., Shimada S., Uno K., et al. Novel subtyping of intestinal metaplasia in the human stomach Brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis . Am J Clin Pathol. 109:1998;181-189.
22. Brito M.J., Filipe M.I., Morris R.W. Cell proliferation study on gastric carcinoma and non-involved gastric mucosa using a bromodeoxyuridine (BrdU) labeling technique. Eur J Cancer Prev. 1:1992;429-435.
23. Hollstein M., Sidransky D., Vogelstein B., et al. p53 mutations in human cancers. Science. 253:1991;49-53.
24. Greenblatt M.S., Bennett W.P., Hollstein M., et al. Mutations in the p53 tumor suppressor gene Clues to cancer etiology and molecular pathogenesis . Cancer Res. 54:1994;4855-4878.
25. Levine A.J., Perry M.E., Chang A., et al. The role of the p53 suppressor gene in tumorigenesis. The 1993 Walter Hubert Lecture. Br J Cancer. 69:1994;409-416.
26. Baker S.J., Preisinger A.C., Jessup M. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
27. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
28. Wada R., Matsukuma S., Abe H., et al. Histopathological studies of superficial-type early colorectal carcinoma. Cancer. 77:1996;44-50.
29. Ohue M., Tomita N., Monden T., et al. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res. 54:1994;4798-4804.
30. Hasegawa T., Ueda M., Furukawa K., et al. p53 gene mutations in early colorectal carcinoma, de novo vs. adenoma-carcinoma sequence. Int J Cancer. 64:1995;47-51.
31. Crawford B.E., Stromeyer F.W. Small nonpolypoid carcinomas of the large intestine. Cancer. 51:1983;1760-1763.
32. Herrera L., Hanna S., Castillio N., et al. Primary de novo adenocarcinoma of the colon measuring 8 mm in diameter with lymph node metastasis. Dis Colon Rectum. 34:1991;275-279.
33. Kuramoto S., Oohara T. Flat early cancers of the large intestine. Cancer. 64:1989;950-955.
34. Ignacio P.C., Baldwin B.A., Vijayan V.K., et al. Brain isozyme of glycogen phosphorylase Immunohistochemical localization within the central nervous system . Brain Res. 529:1990;42-49.
35. Shi S.R., Key M.E., Kalra K.L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues. An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 39:1991;741-748.
36. TNM Atlas An illustrated guide to the TNM/pTNM classification of malignant tumors . 3rd ed. 1993;Springer-Velag, Heidelberg.
37. Sato K., Satoh K., Sato T., et al. Isozyme patterns of glycogen phosphorylase in rat tissues and transplantable hepatomas. Cancer Res. 36:1976;487-495.
38. Matsuda M., Misumi A., Shimada S., et al. Quantitative electron microscopic study on grades of atypia in adenomas of the human large bowel. Dis Col Rect. 32:1989;57-63.
39. McKenzie K.J., Purnell D.M., Shamsuddin A.K.M. Expression of carcinoembryonic antigen, T-antigen and oncogene products as markers of neoplastic and preneoplastic colonic mucosa. Hum Pathol. 18:1987;1282-1286.
40. Xu H.M., Sakamoto K., Shamsuddin A.K. Detection of the tumor marker D-galactose-β-(1-3)-N-acetyl-D-galactosamine in colonic cancer and precancer. Arch Pathol Lab Med. 116:1992;1234-1238.
41. Yang G.Y., Shamsuddin A.M. Gal-GalNac A biomarker of colon carcinogenesis . Histol Histopathol. 11:1996;80-86.
42. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen. Cancer Lett. 37:1987;147-151.
43. Pretlow T.P., Barrow B.J., Ashton W.S., et al. Aberrant crypts Putative preneoplastic foci in human colonic mucosa . Cancer Res. 51:1991;564-567.
44. Shivapurkar N., Huang L., Ruggeri B., et al. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett. 115:1997;39-46.
45. Takayama T., Katsuki S., Takahashi Y., et al. Abberant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 339:1998;1277-1284.
46. Aoki T., Takeda S., Yanagisawa A., et al. APC and p53 mutations in de novo colorectal adenocarcinomas. Human Mutation. 3:1994;342-346.
47. Ichii S., Takeda S., Horii A., et al. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene. 8:1993;3801-3803.